Literature DB >> 16461921

Tensin3 is a novel thyroid-specific gene.

Ikuhiro Maeda1, Toru Takano, Hiroshi Yoshida, Fumio Matsuzuka, Nobuyuki Amino, Akira Miyauchi.   

Abstract

Thyroid-specific genes, such as thyroid peroxidase, thyroglobulin, Na+/I- symporter and thyroid-stimulating hormone receptor, play fundamental roles in thyroid function and relate to many pathological conditions. Using sequence specific-differential display, we detected three genes that showed higher expression levels in normal thyroid tissues than in thyroid tumor tissues. After subcloning and sequencing analysis, one of the genes was revealed to be tensin3. The expression level of tensin3 was examined with real-time quantitative PCR analysis. Its expression levels were more depressed in thyroid tumor tissues than in normal thyroid tissues. The decrease was even more evident in two anaplastic carcinomas. High and moderate levels of tensin3 mRNA expression were observed in the thyroid and placenta respectively. Tensin3 mRNA was expressed only in low levels in other tissues, such as the brain, heart, lung, liver, pancreas, kidney, skeletal muscle, white blood cells and prostate. These results show that tensin3 is a novel thyroid-specific gene and further investigations may reveal its relation to thyroid function or thyroid disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461921     DOI: 10.1677/jme.1.01913

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  2 in total

1.  Functional characterisation of human cells harbouring a novel t(2p;7p) translocation involving TNS3 and EXOC6B genes.

Authors:  Desiree Ludwig; Jessica Carter; James R Smith; Giuseppe Borsani; Sergio Barlati; Sassan Hafizi
Journal:  BMC Med Genet       Date:  2013-06-28       Impact factor: 2.103

2.  Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer.

Authors:  Danuta Martuszewska; Börje Ljungberg; Martin Johansson; Göran Landberg; Cecilia Oslakovic; Björn Dahlbäck; Sassan Hafizi
Journal:  PLoS One       Date:  2009-02-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.